Viscosupplementation Market Size, Share, Trends, Industry Analysis Report: By Product, End Use, and Region

Description

List of Tables

The global viscosupplementation market size is expected to reach USD 15.26 billion by 2034, according to a new study by Polaris Market Research. The report "Viscosupplementation Market Size, Share, Trends, Industry Analysis Report: By Product (Three Injection, Five Injection, and Single Injection), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The viscosupplementation market is experiencing significant growth, driven by the rising prevalence of knee osteoarthritis (OA) and increasing demand for non-surgical treatment options. Viscosupplementation, which involves injecting hyaluronic acid into the knee joint to alleviate pain and improve mobility, has gained widespread acceptance among patients with mild to moderate OA. The market is benefitting from an aging global population, growing awareness of joint health, and advancements in hyaluronic acid formulations, such as single-injection and cross-linked variants, which enhance convenience and efficacy.

The increasing adoption of minimally invasive treatments that offer an alternative to joint replacement surgery is one of the key drivers of the viscosupplementation market expansion. Favorable reimbursement policies in regions like Europe and North America, along with improving healthcare access in emerging economies, have further boosted market demand. Technological advancements and ongoing research into more effective formulations present significant market opportunities for both established players and new entrants.

The viscosupplementation market is poised for sustained market growth, with key players investing in innovation and strategic partnerships to address evolving patient needs and capitalize on emerging opportunities, reinforcing its role as a vital component of osteoarthritis management.

The market outlook is positive, with robust growth expected in Asia Pacific, driven by large elderly populations, rising disposable income, and enhanced healthcare infrastructure. However, challenges such as pricing pressure, competition from alternative treatments, and regulatory hurdles remain.

Key Highlights of Viscosupplementation Market Report

In terms of product, in 2024, the three injection segment accounted for the largest market share due to its established efficacy, widespread availability, and preference among healthcare providers for managing knee osteoarthritis.

Based on end use, the orthopedic clinics/ASCs segment is expected to witness the fastest growth during the forecast period due to increasing patient preference for specialized, cost-effective, and minimally invasive treatments offered in these settings.

In 2024, Asia Pacific accounted for the largest share of the viscosupplementation market due to the region's large aging population and increasing prevalence of knee osteoarthritis.

The Europe viscosupplementation market is expected to witness the fastest CAGR during the forecast period due to increasing demand for advanced osteoarthritis treatments.

A few global key market players include Anika Therapeutics, Inc.; DePuy Synthes; F. Hoffmann-La Roche Ltd.; Ferring Pharmaceuticals B.V.; Fidia Farmaceutici S.p.A, LG Life Sciences Ltd.; Lifecore Biomedical; Sanofi; Seikagaku Corp.; Smith & Nephew PLC; and Zimmer Biomet.

Polaris Market Research has segmented the viscosupplementation market research report on the basis of product, end use, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Three Injection
Five Injection
Single Injection

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Orthopedic Clinics/ASCs
Hospitals

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Vietnam
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

Product Code: PM1015

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Viscosupplementation Market Insights

4.1. Viscosupplementation Market - Market Snapshot
4.2. Viscosupplementation Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Knee Osteoarthritis
  - 4.2.1.2. Growing Aging Population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Treatment Costs
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Viscosupplementation Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Viscosupplementation Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
5.3. Three Injection
- 5.3.1. Global Viscosupplementation Market, by Three Injection, by Region, 2020-2034 (USD Billion)
5.4. Five Injection
- 5.4.1. Global Viscosupplementation Market, by Five Injection, by Region, 2020-2034 (USD Billion)
5.5. Single Injection
- 5.5.1. Global Viscosupplementation Market, by Single Injection, by Region, 2020-2034 (USD Billion)

6. Global Viscosupplementation Market, by End Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
6.3. Orthopedic Clinics/ASCs
- 6.3.1. Global Viscosupplementation Market, by Orthopedic Clinics/ASCs, by Region, 2020-2034 (USD Billion)
6.4. Hospitals
- 6.4.1. Global Viscosupplementation Market, by Hospitals, by Region, 2020-2034 (USD Billion)

7. Global Viscosupplementation Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Viscosupplementation Market Assessment, By Geography, 2020-2034 (USD Billion)
7.3. Viscosupplementation Market - North America
- 7.3.1. North America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.3.2. North America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.3.3. Viscosupplementation Market - U.S.
  - 7.3.3.1. U.S.: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.3.3.2. U.S.: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.3.4. Viscosupplementation Market - Canada
  - 7.3.4.1. Canada: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.3.4.2. Canada: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
7.4. Viscosupplementation Market - Europe
- 7.4.1. Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.4.2. Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.3. Viscosupplementation Market - UK
  - 7.4.3.1. UK: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.3.2. UK: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.4. Viscosupplementation Market - France
  - 7.4.4.1. France: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.4.2. France: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.5. Viscosupplementation Market - Germany
  - 7.4.5.1. Germany: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.5.2. Germany: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.6. Viscosupplementation Market - Italy
  - 7.4.6.1. Italy: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.6.2. Italy: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.7. Viscosupplementation Market - Spain
  - 7.4.7.1. Spain: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.7.2. Spain: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.8. Viscosupplementation Market - Netherlands
  - 7.4.8.1. Netherlands: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.8.2. Netherlands: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.9. Viscosupplementation Market - Russia
  - 7.4.9.1. Russia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.9.2. Russia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.10. Viscosupplementation Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.10.2. Rest of Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
7.5. Viscosupplementation Market - Asia Pacific
- 7.5.1. Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.3. Viscosupplementation Market - China
  - 7.5.3.1. China: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.3.2. China: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.4. Viscosupplementation Market - India
  - 7.5.4.1. India: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.4.2. India: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.5. Viscosupplementation Market - Malaysia
  - 7.5.5.1. Malaysia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.5.2. Malaysia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.6. Viscosupplementation Market - Japan
  - 7.5.6.1. Japan: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.6.2. Japan: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.7. Viscosupplementation Market - Indonesia
  - 7.5.7.1. Indonesia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.7.2. Indonesia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.8. Viscosupplementation Market - South Korea
  - 7.5.8.1. South Korea: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.8.2. South Korea: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.9. Viscosupplementation Market - Australia
  - 7.5.9.1. Australia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.9.2. Australia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.10. Viscosupplementation Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.10.2. Rest of Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
7.6. Viscosupplementation Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.3. Viscosupplementation Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.3.2. Saudi Arabia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.4. Viscosupplementation Market - UAE
  - 7.6.4.1. UAE: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.4.2. UAE: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.5. Viscosupplementation Market - Israel
  - 7.6.5.1. Israel: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.5.2. Israel: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.6. Viscosupplementation Market - South Africa
  - 7.6.6.1. South Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.6.2. South Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.7. Viscosupplementation Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.7.2. Rest of Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
7.7. Viscosupplementation Market - Latin America
- 7.7.1. Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.3. Viscosupplementation Market - Mexico
  - 7.7.3.1. Mexico: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.7.3.2. Mexico: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.4. Viscosupplementation Market - Brazil
  - 7.7.4.1. Brazil: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.7.4.2. Brazil: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.5. Viscosupplementation Market - Argentina
  - 7.7.5.1. Argentina: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.7.5.2. Argentina: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.6. Viscosupplementation Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.7.6.2. Rest of Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Anika Therapeutics, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. DePuy Synthes
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. F.Hoffmann-La Roche Ltd.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Ferring Pharmaceuticals B.V.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Fidia Farmaceutici S.p.A
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. LG Life Sciences Ltd.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Lifecore Biomedical
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Sanofi
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Seikagaku Corp.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Smith & Nephew PLC
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Zimmer Biomet
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development